You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 1, January 1, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Corticosteroids for Patients With Septic Shock

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Annane and colleagues1 reported a reduction in the risk of death among vasopressor-dependent septic shock patients with relative adrenal insufficiency when treated with low-dose hydrocortisone and fludrocortisone. Adrenal insufficiency was assessed by measuring cortisol level increase following a short 250-µg corticotropin stimulating test. However, some recent studies have shown the low-dose corticotropin stimulating test (1 µg) to have an increased accuracy in detecting relative adrenal insufficiency over the conventional test (250 µg).2-4 We wonder if the conventional corticotropin dose might have caused normal responses in patients with secondary adrenal insufficiency by overriding adrenal resistance to corticotropin. Consequently this might have led to mixing patients who could have benefited from corticosteroid therapy in the responder group. In light of the results of this study, this could have a considerable impact on the outcome of such patients reducing mortality difference between responders and nonresponders.

We are also concerned . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Corticosteroids for Patients With Septic Shock
Julian M. Brown
JAMA. 2003;289(1):41.
EXTRACT | FULL TEXT  

Corticosteroids for Patients With Septic Shock
Christina L. Schenarts and Juan A. March
JAMA. 2003;289(1):41.
EXTRACT | FULL TEXT  

Corticosteroids for Patients With Septic Shock
Julian Millo
JAMA. 2003;289(1):41.
EXTRACT | FULL TEXT  

Corticosteroids for Patients With Septic Shock
Steven M. Opal
JAMA. 2003;289(1):41-42.
EXTRACT | FULL TEXT  

Corticosteroids for Patients With Septic Shock
Jan G. Zijlstra, Iwan C. C. van der Horst, Jaap E. Tulleken, Tjip S. van der Werf, and Jack J. M. Ligtenberg
JAMA. 2003;289(1):42.
EXTRACT | FULL TEXT  

Corticosteroids for Patients With Septic Shock
Babak Mokhlesi
JAMA. 2003;289(1):43.
EXTRACT | FULL TEXT  

Corticosteroids for Patients With Septic Shock
Djillali Annane, Véronique Sebille, and Eric Bellissant
JAMA. 2003;289(1):43-44.
EXTRACT | FULL TEXT  

Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock
Djillali Annane, Véronique Sébille, Claire Charpentier, Pierre-Edouard Bollaert, Bruno François, Jean-Michel Korach, Gilles Capellier, Yves Cohen, Elie Azoulay, Gilles Troché, Philippe Chaumet-Riffaut, and Eric Bellissant
JAMA. 2002;288(7):862-871.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.